Marico Q1 FY27 Update: Revenue Growth Seen Early 20s

Results date and board meeting

Marico has scheduled a board meeting for August 04, 2026 to consider and approve the audited financial results for the quarter ended June 30, 2026 (Q1 FY27). The announcement has put the stock back in focus, coming soon after the company’s operating update for the quarter. Marico said a detailed information update, including unaudited consolidated and standalone financial results, will follow once the Board of Directors formally approves the numbers.

The Q1 FY27 operating update covered demand trends and business performance across India and overseas markets. It highlighted volume-led traction in India, continued growth in parts of the international portfolio, and mixed trends within the foods and edible oils segments. Alongside the operational commentary, input-cost movements, particularly copra and crude palm oil, have remained central to the market’s margin expectations.

What the Q1 FY27 update said on demand

Marico said demand conditions were steady, supported by resilient economic activity. The company reported double-digit underlying volume growth in India, describing it as a multi-quarter high. Parachute Coconut Oil posted double-digit volume growth and delivered its best performance in several quarters.

Value Added Hair Oils (VAHO) and newer segments such as Foods and Premium Personal Care were also described as scaling. But Saffola Oils saw lower volumes due to selective supply optimisation, even as revenue grew. Marico also guided that consolidated revenue is expected to grow in the early twenties for the quarter, indicating broad-based strength across its core, digital, and international businesses.

India business: Parachute leads, VAHO stays strong

The India business was the key driver in the update, with the company pointing to double-digit underlying volume growth. Parachute’s performance was positioned as a standout, with volume growth at a multi-quarter high. The commentary suggests that the core franchise has regained momentum after a period influenced by price increases linked to commodity inflation.

VAHO revenue growth was indicated to be in the twenties. Marico also said new-age categories, including Foods and Premium Personal Care, continued to expand. For investors, the India narrative mattered because it combined volume growth with brand-led execution, even as input-cost benefits begin to show up more clearly.

Saffola Oils: revenue up, volumes down on optimisation

Marico said Saffola Oils delivered revenue growth, but volumes declined due to selective supply optimisation. The company’s update described Saffola Oils revenue growth as mid-single digit and price-led. That mix matters because it signals that the segment’s near-term growth is not purely demand-driven and is being shaped by portfolio and supply decisions.

The broader edible oils environment also remained challenging. The context provided pointed to crude palm oil (CPO) import prices being 14-15% higher year-on-year in April 2026. That creates a different margin setup for Saffola compared with hair oils, which are more directly linked to copra.

International business: mid-teens growth, Bangladesh softer

International operations maintained momentum, with Marico reporting mid-teens constant currency revenue growth in Q1 FY27. The update attributed support to Vietnam and the MENA region. Bangladesh, however, saw temporary moderation due to pricing effects and softer demand in a high-inflation environment.

The split is important because Marico’s international business can add to consolidated growth, but country-specific inflation and pricing cycles can influence short-term performance. The company’s update, as presented, indicated that the consolidated growth outlook is not dependent on a single geography.

Input costs and margins: copra tailwind vs CPO headwind

A key driver for the quarter’s operating profit expectations has been copra. Marico was expected to report strong operating profit growth in Q1, driven primarily by a 45% decline in copra prices from their peak levels. This softening is typically supportive for the hair oils portfolio, where copra is a major raw material.

At the same time, Saffola faces a different commodity basket, with CPO import prices cited as 14-15% higher year-on-year in April 2026. The market’s margin debate has therefore centred on how management balances these mixed input cost dynamics. The company’s prior-year context also anchors expectations, with Marico seeking to improve upon the approximately 17.1% EBITDA margin recorded in the previous fiscal year.

Stock moves, valuation, and what investors are tracking

Marico’s share price touched an all-time high of ₹873.00 during intraday trade on July 3, 2026. The stock later retreated and was reported trading at ₹841.40 as of 12:05 PM, down 1.5% on that day. In another update, the stock was cited at ₹841.15 at 10:20 AM, falling 1.73%, after hitting an intraday low of ₹839.20.

The provided data also cited a CMP of ₹885.0, and a price of ₹874.00 per share compared with the previous closing price of ₹856.25. On valuation, Marico was noted to trade at a P/E of 62.0 with a market cap of ₹109,194 crore. These reference points indicate heightened attention on execution and margin recovery, given the stock’s pricing.

Brokerages: Buy calls after the operating update

Following the Q1 FY27 business update, major global brokerages were cited with Buy ratings. HSBC set a target price of ₹1,000 (raised), Nomura a target of ₹950, and Goldman Sachs a target of ₹900. Their positive stance was linked to double-digit India volume growth led by Parachute, 20%+ VAHO revenue growth, a strong EBITDA outlook, and robust international performance in Vietnam and MENA, while also flagging Bangladesh as a weaker spot.

The same commentary pointed to sequential gross margin improvement supported by the roughly 45% correction in copra prices from peak levels. The combination of volume traction and commodity relief is a key reason brokerages have focused on the operating leverage potential in the near term.

Key financial context from recent periods

Marico’s FY26 results provide context for the current margin and growth conversation. For FY26, consolidated revenue from operations rose to ₹13,611 crore from ₹10,831 crore, while net profit grew to ₹1,813 crore from ₹1,658 crore. In Q4 FY26, revenue rose 22.09% year-on-year to ₹3,333 crore from ₹2,730 crore, while net profit increased to ₹408 crore from ₹345 crore.

For Q1 FY26 (June 2025 quarter), Marico reported consolidated revenue from operations of ₹3,259 crore, up 23% year-on-year from ₹2,643 crore. The India business revenue was ₹2,495 crore, up 27% year-on-year, aided by price hikes in core portfolios in response to sharp input-cost inflation. Separately, Q1 performance was also described as consolidated revenue of ₹3,260 crore (23.5% growth) and net profit of ₹504 crore (9.6% growth), using the same quarter reference.

Corporate development: board change

Marico also disclosed a board-level change. Independent Director Mr. Milind Barve will retire from the Board effective August 1, 2026, due to persistent health issues. While this is separate from the quarterly performance update, investors typically track board composition changes alongside results timelines.

Summary table: what Marico indicated for Q1 FY27

What to watch as audited results approach

With the board meeting set for August 04, 2026, the immediate next step is the approval and release of the quarter’s audited financial results for the period ended June 30, 2026. Investors will watch how the early-twenties revenue growth guidance translates into reported numbers and how much of the copra correction reflects in gross margin and EBITDA.

Attention is also likely to stay on Saffola’s volume trajectory amid supply optimisation, and on Bangladesh’s demand environment, given the company’s reference to pricing effects and softer consumption in a high-inflation setting. The broader demand backdrop has been described as resilient, with domestic demand supported by 8.4% year-on-year growth in Q1 GST collections, which provides context for volume expansion.

Conclusion

Marico’s Q1 FY27 operating update pointed to double-digit India volumes, mid-teens international growth, and consolidated revenue growth expected in the early twenties. Margin expectations remain tied to a favourable copra trend, partially offset by higher CPO-linked costs affecting the Saffola edible oils business. The next concrete trigger is the August 04, 2026 board meeting, after which the company said it will release detailed financial information once the numbers are formally approved.